Literature DB >> 12782759

Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas.

P Zauber1, M Sabbath-Solitare, S P Marotta, D T Bishop.   

Abstract

AIMS: To compare the molecular genetic changes in the Ki-ras and adenomatous polyposis coli (APC) genes between colorectal carcinomas and synchronous metastases, and then to compare and contrast those changes with previously reported changes in the two genes between these carcinomas and accompanying adenomas. This expanded comparison would provide greater understanding of the progression of molecular changes in neoplastic tissue during the development of malignancy from a benign adenoma to carcinoma and then to metastatic spread of the malignancy.
METHODS: DNA was extracted from paraffin wax embedded tissue. This was followed by polymerase chain reaction and gel electrophoresis for mutations in the Ki-ras gene using single stranded conformational polymorphism analysis. Amplification of a CA repeat marker was used to assess loss of heterozygosity (LOH) at the APC gene.
RESULTS: The findings for the Ki-ras gene in 42 paired carcinomas and synchronous metastases were identical, regardless of whether or not the carcinoma and its companion adenoma had identical Ki-ras findings. The results of APC LOH for 39 paired carcinomas and synchronous metastases were also identical, whether or not the carcinoma and its companion adenoma had identical APC LOH findings. Results were uninformative for three pairs.
CONCLUSIONS: With respect to these two genes, a carcinoma may be discordant from its companion adenoma, but the metastasis remains consistent with the colonic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782759      PMCID: PMC1187308          DOI: 10.1136/mp.56.3.137

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  12 in total

1.  Ki-ras mutations in adenomas from cancer-bearing and cancer-free bowel.

Authors:  N P Zauber; M Sabbath-Solitaire; D T Bishop
Journal:  J Pathol       Date:  1998-03       Impact factor: 7.996

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes.

Authors:  A Paredes-Zaglul; J J Kang; Y P Essig; W Mao; R Irby; M Wloch; T J Yeatman
Journal:  Clin Cancer Res       Date:  1998-04       Impact factor: 12.531

4.  Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.

Authors:  N P Zauber; M Sabbath-Solitare; S P Marotta; A G Zauber; D T Bishop
Journal:  J Pathol       Date:  2001-03       Impact factor: 7.996

5.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases.

Authors:  F Al-Mulla; W N Keith; I R Pickford; J J Going; G D Birnie
Journal:  Genes Chromosomes Cancer       Date:  1999-04       Impact factor: 5.006

7.  Stability of K-ras mutations throughout the natural history of human colorectal cancer.

Authors:  L Losi; J Benhattar; J Costa
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

8.  Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases.

Authors:  H Bläker; M Graf; R J Rieker; H F Otto
Journal:  J Pathol       Date:  1999-07       Impact factor: 7.996

9.  Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.

Authors:  F Al-Mulla; J J Going; E T Sowden; A Winter; I R Pickford; G D Birnie
Journal:  J Pathol       Date:  1998-06       Impact factor: 7.996

10.  A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene.

Authors:  L Spirio; G Joslyn; L Nelson; M Leppert; R White
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

View more
  25 in total

Review 1.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

Review 2.  Molecular alterations and biomarkers in colorectal cancer.

Authors:  William M Grady; Colin C Pritchard
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

3.  Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.

Authors:  Matthias P A Ebert; Suzanne H Mooney; Lori Tonnes-Priddy; Joe Lograsso; Juliane Hoffmann; Jie Chen; Christoph Röcken; Hans-Ulrich Schulz; Peter Malfertheiner; Catherine Lofton-Day
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

4.  Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.

Authors:  Maria Arcila; Christopher Lau; Khedoudja Nafa; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

Review 5.  Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

Authors:  Armand de Gramont; Sarah Watson; Lee M Ellis; Jordi Rodón; Josep Tabernero; Aimery de Gramont; Stanley R Hamilton
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

Review 6.  Tumour heterogeneity: principles and practical consequences.

Authors:  Giorgio Stanta; Stephan Wenzel Jahn; Serena Bonin; Gerald Hoefler
Journal:  Virchows Arch       Date:  2016-07-13       Impact factor: 4.064

7.  Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.

Authors:  Satu Oltedal; Ole Gunnar Aasprong; Jannicke H Møller; Hartwig Kørner; Bjørnar Gilje; Kjersti Tjensvoll; Elke M Birkemeyer; Reino Heikkilä; Rune Smaaland; Oddmund Nordgård
Journal:  Int J Colorectal Dis       Date:  2011-05-15       Impact factor: 2.571

Review 8.  Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Authors:  Jara M Baas; Lisanne L Krens; Henk-Jan Guchelaar; Hans Morreau; Hans Gelderblom
Journal:  Oncologist       Date:  2011-07-08

9.  Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.

Authors:  Kenta Kawasaki; Yasuo Hamamoto; Takeshi Suzuki; Kenro Hirata; Yasutaka Sukawa; Akiyoshi Kasuga; Yuichiro Hayashi; Hiromasa Takaishi; Kaori Kameyama; Takanori Kanai
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

Review 10.  Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

Authors:  Hui-Yan Luo; Rui-Hua Xu
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.